Inflammatix is developing novel molecular diagnostics for acute infections and sepsis that work by ‘reading’ the immune system. Founded by Jonathan Romanowsky, Purvesh Khatri, and Tim Sweeney in 2016, Inflammatix is backed by investors that include StartX (Stanford-StartX Fund), Khosla Ventures, DARPA, Northpond Ventures, and Think.Health and is headquartered in Burlingame, California.
FOUNDED:
2016
INDUSTRY:
Big Data, Bioinformatics, Health Diagnostics
FOUNDERS:
Jonathan Romanowsky, Purvesh Khatri, Tim Sweeney
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
